Laurus Labs Limited — Important, 06-03-2025: General Updates

The Board of Directors has approved an investment of INR 833 crore in KRKA Pharma Private Limited, a joint venture aimed at establishing a manufacturing facility for finished products targeting new markets, including India. KRKA d.d., Novo mesto, Slovenia, will also invest INR 867 crore to maintain the existing ownership ratio of 51:49. This strategic move aligns with Laurus Labs’ growth objectives, positioning the company to enhance its operational capacity and market reach. Investors should view this development positively, given its potential to drive future revenue growth and solidify the company's footprint in the pharmaceutical industry. Expected completion of the investment is by March 31, 2025.